Industry

 

Add Remote Patient Monitoring to your Drug Delivery Device or Medical Device Technology Today!



To reduce healthcare costs, payers are now requiring patient compliance evidence for reimbursement for certain therapy categories, and this trend is expected to broaden.

For medical device and drug delivery companies this leaves two options: develop in-house or partner.

Partnering with Nexus6 provides the following advantages:
* creates new annuity revenue streams
* accelerates time to market
* reduces R&D & management costs
* reduces risk with Nexus6's proven technology

Nexus6 will add remote patient monitoring to your medical device or drug delivery technology in three stages:





Nexus6 Remote Monitoring Evaluation System
Reduces Time To Market 
and Reduces Development Risk

For more information, please contact :
Garth Sutherland, Chief Operating Officer
Tel: (937) 274 2111 ext 104

Announcements

MicroDose - Nexus6 Global Partnership. Nov 10

MicroDose and Nexus6 Announce Worldwide Partnership to Commercialize the SmartInhalerLiveTM Technology with MicroDose’s Electronic Dry Powder Inhalers 

Nexus6 Signs OEM co-development agreement. Jun 09

Nexus6 signs another OEM co-development agreement with a leading global healthcare company to add Nexus6's remote patient compliance monitoring technology to their device platform. 

MicroDose - Nexus6. Jan 09

MicroDose Therapeutx (MDT) and Nexus6 Ltd announce collaboration to evaluate application of remote patient compliance monitoring technology with MDT's electronic dry powder inhaler.
read more... 

Our Apps

Follow Us On

SmartinhalerLive Reporting Software

Data Stored In

  • Nexus6 Database
  • SmartinhalerLive.com
also available

Subscribe

Please enter your email address
 
  

Industry Video Featuring Nexus6